Yao Chang Xu
Chief Executive Officer presso ABBISKO CAYMAN LIMITED
Patrimonio netto: 31 M $ in data 31/03/2024
Profilo
Yao Chang Xu is the founder of Abbisko Therapeutics Co., Ltd.
(founded in 2016) and Abbisko Cayman Ltd.
(founded in 2016).
He is currently a Director at Abbisko Hong Kong Ltd.
(since 2018), Wuxi Abbisko Biomedical Technology Co. Ltd.
(since 2020), and Abbisko Therapeutics Australia Pty Ltd.
(since 2020).
Dr. Xu's former positions include Executive Director at Novartis International AG (2006-2012), Head-Discovery Chemistry at Eli Lilly & Co. (1993-2006), and General Manager at Hansoh Pharmaceutical Group Co., Ltd.
(2012-2016) and Shanghai Hansoh Biomedical Co. Ltd.
(2012-2016).
Dr. Xu received his doctorate degree from The University of Chicago in 1988 and his undergraduate degree from Nanjing University in 1982.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED
11.86% | 02/04/2024 | 83 297 074 ( 11.86% ) | 31 M $ | 31/03/2024 |
Posizioni attive di Yao Chang Xu
| Società | Posizione | Inizio |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Chief Executive Officer | 28/03/2018 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Chief Executive Officer | 12/04/2016 |
| Abbisko Hong Kong Ltd. | Director/Board Member | 01/04/2018 |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | Director/Board Member | 01/07/2020 |
| Abbisko Therapeutics Australia Pty Ltd. | Director/Board Member | 01/12/2020 |
Precedenti posizioni note di Yao Chang Xu
| Società | Posizione | Fine |
|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | 01/03/2016 |
| Shanghai Hansoh Biomedical Co. Ltd. | Corporate Officer/Principal | 01/03/2016 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Director/Board Member | 01/03/2012 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 |
Formazione di Yao Chang Xu
| The University of Chicago | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| Aziende private | 6 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Hansoh Biomedical Co. Ltd. | |
| Abbisko Hong Kong Ltd. | |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | |
| Abbisko Therapeutics Australia Pty Ltd. |
- Borsa valori
- Insiders
- Yao Chang Xu
